Pharmacology of Asthma Flashcards
What is the mechanism of action of Salbutimol?
Agonist at the β2 receptor on airway smooth muscle cells. Activation reduces Ca2+ entry and this prevents smooth muscle contraction.
What is the drug target for Salbutimol?
Beta 2 (β2) adrenergic receptor
What are the main side effects of Salbutimol?
Palpitations/ agitation
Tachycardia/ Arrythmias
Hypokalaemia (at higher doses)
What is Salbutimol’s half life?
Salbutamol is a short acting beta agonist (SABA). It’s half life is 2.5-5hours.
How do you get cardiac effects from Salbutimol?
Beta 2 selectivity is not absolute, so you can get some beta 1 (cardiac effects).
How do you get Hypokalaemia from Salbutimol?
Hypokalaemia can be caused via an effect on sodium/ potassium ATPase. This effect can be exacerbated by coadministration with corticosteroids
What is the mechanism of action of Fluticasone, Mometasone, Budenoside?
Multiple actions on many different cell types. Fluticasone directly decreases inflammatory cells such as eosinophils, monocytes, mast cells, macrophages, and dendritic cells. It reduces the number of these cells and also the number of cytokines they produce.
What is the target of Fluticasone, Mometasone, Budesonide?
Glucocorticoid receptor - greater affinity than cortisol
What are local side effects of Fluticasone, Mometasone, Budesonide?
Sore throat, hoarse voice, opportunistic oral infections
What are systemic side effects of Fluticasone, Mometasone, Budesonide?
Growth retardation in children
Hyperglycaemia
Decreased bone mineral density
Immunosuppression
Effects on mood
(Many others)
How is Fluticasone, Mometasone systematically delivered?
Oral bioavailability <1%. Therefore, any systemic delivery via the inhaled route is predominantly through the pulmonary vasculature.
How is Budesonide systematically delivered?
Oral bioavailability >10%. Therefore, inhaled budesonide will still result in some systemic absorption through the gastro-intestinal tract.
What is the least potent out of Fluticasone, Mometasone & Budesonide
Budesonide
What is the mechanism of action of Montelukast?
Antagonism of CysLT1 leukotriene receptor on eosinophils, mast cells and airway smooth muscle cells decreases eosinophil migration, broncho-constriction and inflammation induced oedema
What is the target for Montelukast?
CysLT1 leukotriene receptor